Application | Comment | Organism |
---|---|---|
drug development | the toxin is a target for development of inhibitors to treat muscular paralysis, and of drugs altering BoNT/B light chain ubiquitination to overcome botulinum persistence in neuronal cells | Clostridium botulinum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
expoxomicin | increases ubiquitination of BoNT/B light chain in neuronal cells. Ubiquitination in vitro and in cells decreases the biological activity of BoNT/B light chain | Clostridium botulinum | |
additional information | BoNT/B LC is processed for removal via the proteasome-dependent degradation pathway after ubiquitination in neuronal cells | Clostridium botulinum | |
phorbol 12-myristate 13-acetate | increases ubiquitination of BoNT/B light chain in neuronal cells. Ubiquitination in vitro and in cells decreases the biological activity of BoNT/B light chain | Clostridium botulinum |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | a zinc-dependent endopeptidase | Clostridium botulinum |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
VAMP 2 + H2O | Clostridium botulinum | i.e. synaptobrevin-2 or vesicle-associated membrane protein 2 | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Clostridium botulinum | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
additional information | BoNT/B LC is processed for removal via the proteasome-dependent degradation pathway after ubiquitination in neuronal cells | Clostridium botulinum |
Source Tissue | Comment | Organism | Textmining |
---|
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | assay method measuring noradrenaline release in human neuronal SHSY-5Y cells | Clostridium botulinum | ? | - |
? | |
VAMP 2 + H2O | i.e. synaptobrevin-2 or vesicle-associated membrane protein 2 | Clostridium botulinum | ? | - |
? | |
VAMP 2 + H2O | i.e. synaptobrevin-2 or vesicle-associated membrane protein 2, with BoNT/B light chain | Clostridium botulinum | ? | - |
? | |
VAMPTide + H2O | a VAMP-2-derived peptide substrate, modified with FRET, with BoNT/B light chain | Clostridium botulinum | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
BoNT/B | - |
Clostridium botulinum |
botulinum neurotoxin B | - |
Clostridium botulinum |
General Information | Comment | Organism |
---|---|---|
additional information | the toxin persists in neuronal cells for an extended period, it maintaines its ability to cleave VAMP2 in human neuronal cells for weeks | Clostridium botulinum |
physiological function | after entering its target, the neuronal cell, BoNT/B is responsible for synaptobrevin-2, i.e. VAMP2, cleavage. This results in reduced neurotransmitter acetylcholine release from synaptic vesicles, yielding muscular paralysis | Clostridium botulinum |